EFFECTS OF ALCOHOL AND NICOTINE ON CYTOTOXIC FUNCTIONS OF HUMAN-LYMPHOCYTES

被引:56
作者
NAIR, MPN
KRONFOL, ZA
SCHWARTZ, SA
机构
[1] UNIV MICHIGAN, DEPT EPIDEMIOL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, DEPT PSYCHIAT, ANN ARBOR, MI 48109 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1990年 / 54卷 / 03期
关键词
D O I
10.1016/0090-1229(90)90053-S
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The in vitro effects of the recreational drugs, ethanol (EtOH) and nicotine, on natural killer (NK) antibody-dependent cellular cytotoxic (ADCC) and lymphokine-activated killer (LAK) cell activities on normal lymphocytes were investigated. Lymphocytes precultured with EtOH at concentrations of 0.4 and 0.6% (v/v) produced significant suppression of NK and ADCC activities. In target-binding assays, EtOH decreased the target-binding capacity of effector cells. EtOH also inhibited the activities of Percoll-separated, NK-enriched large granular lymphocytes. EtOH-induced inhibition of NK activity could be reversed by incubating lymphocytes for 1 hr with interferon. The generation and lytic capacity of LAK cells was also significantly depressed by EtOH when added at the initiation of culture. Nicotine at concentrations of 5 and 10 μg/ml, when added directly to mixtures of effector and target cells, produced significant inhibition of NK activity. Nicotine (2 μg/ml) and EtOH (0.01, 0.1, and 0.2%) at noninhibitory concentrations when added separately, showed significant suppression of NK activity when used in combination. Pretreatment of target cells with either EtOH or nicotine for 4 hr did not affect cytotoxic activity. Inhibition of cytotoxicity was also not due to direct toxicity of effector cells because lymphocytes treated with either EtOH or nicotine showed normal 51Cr release and their viability was comparable to that of untreated control cells. These studies demonstrate that EtOH and nicotine have significant immunomodulatory effects on the cytotoxic activities of human lymphocytes which may be of clinical relevance. © 1990.
引用
收藏
页码:395 / 409
页数:15
相关论文
共 48 条
[1]  
ABDALLAH RM, 1983, IMMUNOLOGY, V50, P131
[2]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]  
CHARPENTIER B, 1984, CLIN EXP IMMUNOL, V58, P107
[5]  
CORRE F, 1971, LANCET, V2, P632
[6]   NOREPINEPHRINE AND EPINEPHRINE RELEASE AND ADRENERGIC MEDIATION OF SMOKING-ASSOCIATED HEMODYNAMIC AND METABOLIC EVENTS [J].
CRYER, PE ;
HAYMOND, MW ;
SANTIAGO, JV ;
SHAH, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (11) :573-577
[7]  
DAMLE NK, 1986, J IMMUNOL, V137, P2814
[8]   CHANGES IN SIZE, SUBCLASS, AND METABOLIC PROPERTIES OF SERUM IMMUNOGLOBULIN-A IN LIVER-DISEASES AND IN OTHER DISEASES WITH HIGH SERUM IMMUNOGLOBULIN-A [J].
DELACROIX, DL ;
ELKON, KB ;
GEUBEL, AP ;
HODGSON, HF ;
DIVE, C ;
VAERMAN, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (02) :358-367
[9]   MORTALITY IN RELATION TO SMOKING - 20 YEARS OBSERVATIONS ON MALE BRITISH DOCTORS [J].
DOLL, R ;
PETO, R .
BRITISH MEDICAL JOURNAL, 1976, 2 (6051) :1525-1536
[10]  
DREW PA, 1984, CLIN EXP IMMUNOL, V57, P479